Studying the Impact of Presence of Alpha Acid Glycoprotein and Protein Glycoprotein in Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate in the State of Qatar

por Al-Dewik, Nader I., Jewell, Andrew P., Yassin, Mohammed A., Morsi, Hisham M.
Publicado 2015

Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients

por Ismail, Mohamed A., Vezzalini, Marzia, Morsi, Hisham, Abujaber, Ahmad, Al Sayab, Ali, Siveen, Kodappully, Yassin, Mohamed A., Monne, Maria, Samara, Muthanna, Cook, Richard, Sorio, Claudio, Modjtahedi, Helmout, Al-Dewik, Nader I.
Publicado 2021

Aberrant DNA methylation of PTPRG as one possible mechanism of its under‐expression in CML patients in the State of Qatar

por Ismail, Mohamed A., Samara, Muthanna, Al Sayab, Ali, Alsharshani, Mohamed, Yassin, Mohamed A., Varadharaj, Govindarajulu, Vezzalini, Marzia, Tomasello, Luisa, Monne, Maria, Morsi, Hisham, Qoronfleh, M. Walid, Zayed, Hatem, Cook, Richard, Sorio, Claudio, Modjtahedi, Helmout, Al‐Dewik, Nader I.
Publicado 2020

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

por Al-Dewik, Nader I., Morsi, Hisham M., Samara, Muthanna M., Ghasoub, Rola S., Gnanam, Cinquea C., Bhaskaran, Subi K., Nashwan, Abdulqadir J., Al-Jurf, Rana M., Ismail, Mohamed A., AlSharshani, Mohammed M., AlSayab, Ali A., Ben-Omran, Tawfeg I., Khatib, Rani B., Yassin, Mohamed A.
Publicado 2016

Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar

por Al‐Sharshani, Dalal, Velayutham, Dinesh, Samara, Muthanna, Gazal, Reham, Al Haj Zen, Ayman, Ismail, Mohamed A., Ahmed, Mahmoud, Nasrallah, Gheyath, Younes, Salma, Rizk, Nasser, Hammuda, Sara, Qoronfleh, M. Walid, Farrell, Thomas, Zayed, Hatem, Abdulrouf, Palli Valapila, AlDweik, Manar, Silang, John Paul Ben, Rahhal, Alaa, Al‐Jurf, Rana, Mahfouz, Ahmed, Salam, Amar, Al Rifai, Hilal, Al‐Dewik, Nader I.
Publicado 2023